United States Protein Therapeutics Market to Reach USD 657.12 Billion by 2033, Growing at 6.6% CAGR | Abbott Laboratories, Amgen Inc., Baxter International Inc.

The global protein therapeutics market size reached US$ 349.83 billion with rise of US$ 371.13 billion in 2024 is expected to reach US$ 657.12 billion by 2033, growing at a CAGR of 6.6% during the forecast period 2025-2033.

Protein therapeutics are biopharmaceuticals composed of natural or engineered proteins used to treat diseases. They include monoclonal antibodies, enzymes, hormones, and cytokines. These therapies offer high specificity, reduced side effects, and potent biological activity. Protein drugs are widely used in cancer, autoimmune, and metabolic disorders. Advances in recombinant DNA and cell culture technology drive innovation in this field. Challenges include stability, cost, and complex manufacturing processes.

📌 Download Sample Report to Identify Emerging Deals & Opportunities in the Protein Therapeutics Market Landscape:- https://datamintelligence.com/download-sample/protein-therapeutics-market?Ranjith

☛ Protein Therapeutics Market Recent Developments 2025:

United States: Recent Industry Developments

✅ In July 2025, Amgen Inc. announced FDA approval of a next-generation protein therapeutic for autoimmune diseases, demonstrating improved efficacy and reduced immunogenicity.

✅ In June 2025, Genentech (Roche Group) launched engineered antibody therapies targeting cancer-specific antigens, leveraging bispecific protein constructs for enhanced tumor cell killing.

✅ In May 2025, Regeneron Pharmaceuticals expanded its protein therapeutic pipeline with novel fusion proteins aimed at treating metabolic disorders and rare genetic diseases.

Japan: Recent Industry Developments

✅ In July 2025, Chugai Pharmaceutical initiated clinical trials for engineered protein therapeutics targeting inflammatory and fibrotic diseases, focusing on high specificity and long half-life.

✅ In June 2025, Astellas Pharma advanced recombinant protein therapies for oncology applications, emphasizing improved delivery mechanisms and reduced off-target effects.

✅ In May 2025, Daiichi Sankyo partnered with academic institutions to develop next-generation protein therapeutics for rare genetic disorders, integrating precision medicine and biologics innovation.

☛ Protein Therapeutics Market Competitive Landscape:

Abbott Laboratories, Amgen Inc., Baxter International Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Johnson & Johnson, Merck & Co, Inc, Novo Nordisk A/S, Pfizer Inc., Sanofi SA.

Research Methodology

We follow a hybrid research approach, combining qualitative insights with rigorous quantitative analysis to deliver reliable and comprehensive market intelligence. Our process begins with extensive secondary research, drawing on trusted industry reports, proprietary databases, and credible market sources. This is then reinforced through targeted primary research, including structured surveys and in-depth interviews with industry leaders, subject matter experts, and key market participants.

📌 Request a Customized Market Report - Tailored insights to match your business goals: https://datamintelligence.com/customize/protein-therapeutics-market?Ranjith

☛ Segments Covered in the Protein Therapeutics Market:

By Product: Blood Clotting Factors, Monoclonal Antibodies, Insulin, Fusion Protein, Human Growth Hormone, Follicle Stimulating Hormone, Others

By Application: Cancer, Hormonal Disorder, Genetic Disorder, Metabolic Disorders, Immunologic Disorders, Haematological Disorders, Others

☛ This Report Includes:

✔ Comprehensive go-to-market strategies with actionable insights.

✔ Unbiased evaluation of overall market performance.

✔ Deep-dive analysis into development trends, competitive landscape, supply-demand dynamics, YoY growth, benchmarking, vendor mapping, market access, and overall progress.

✔ Tailored regional and country-level reports with detailed localized analysis available on request.

✔ Identification of niche segments and high-growth regions presenting strong opportunities.

✔ Accurate regional forecasts using both top-down and bottom-up approaches.

📌 Get Corporate Access to Live Protein Therapeutics Industry Intelligence Database: https://www.datamintelligence.com/buy-now-page?report=protein-therapeutics-market?Ranjith

☛ Regional Analysis for Protein Therapeutics Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription

☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.